sPD-1/sPD-L1 proteins in non-small cell lung cancer and esophageal squamous cell carcinoma

Background. Implementation of immunotherapy in clinical oncological practice has significantly improved the results of cancer treatment. It resulted in the need for seeking new markers to assess the effectiveness of therapy and the disease prognosis.Aim. To analyze the content of soluble forms of PD...

Descrizione completa

Dettagli Bibliografici

Autori principali:	I. S. Stilidi, O. V. Kovaleva, A. N. Gratchev, E. M. Tchevkina, P. A. Podlesnaya, P. V. Tsarapaev, E. A. Suleymanov, N. E. Kushlinskii
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Siberian State Medical University (Tomsk) 2022-10-01
Serie:	Бюллетень сибирской медицины
Soggetti:	spd-1 spd-l1 immunotherapy non-small cell lung cancer esophageal cancer prognosis
Accesso online:	https://bulletin.ssmu.ru/jour/article/view/4912
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!